Penumbra Q3 net income falls 8% to $42.28 million; Q3 revenue rises 16% to $410.15 million

Bitget2026/10/29 20:19

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Penumbra's third-quarter 2026 net income fell 8% year over year to $42.28 million.
Revenue rose 16% year over year to $410.15 million.
Global thrombectomy revenue climbed 18% year over year to $279.16 million.
The company will not provide full-year 2026 guidance given its pending acquisition by Boston Scientific.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Penumbra Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610291605PR_NEWS_USPR_____SF83735) on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Penumbra Q3 net income falls 8% to $42.28 million; Q3 revenue rises 16% to $410.15 million

You may also like

Crypto prices